azathioprine has been researched along with omeprazole in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ashby, J | 1 |
| Meiser, BM; Muschiol, F; Nollert, G; Pfeiffer, M; Reichart, B; Reichenspurner, H; Uberfuhr, P; Vetter, HO; Wagner, F | 1 |
| Azuma, J; Yamamoto, I | 1 |
| De Silva, M; Prasad, R | 1 |
| Hinner, H; Kraus, J; Schuppert, F; Tiesmeier, J | 1 |
| Akbulut, S; Gököz, A; Köseoğlu, T; Saritaş, U; Yavuz, B | 1 |
| Kunicki, PK; Sobieszczańska-Małek, M | 1 |
| Bruijnzeel-Koomen, CA; de Bruin-Weller, MS; van den Broek, MP; van der Schaft, J; van Schaik, RH | 1 |
| Balendran, K; Nawaraththne, NMM; Udumalagala, S | 1 |
3 review(s) available for azathioprine and omeprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Consideration of CASE predictions of genotoxic carcinogenesis for omeprazole, methapyrilene and azathioprine.
Topics: Azathioprine; Carcinogens; Methapyrilene; Omeprazole; Software; Structure-Activity Relationship | 1992 |
[Individualization of drug therapy and pharmacogenetics].
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Arylamine N-Acetyltransferase; Azathioprine; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Genetic Variation; Humans; Immunosuppressive Agents; Methyltransferases; Mixed Function Oxygenases; Mutation; Omeprazole; Polymorphism, Genetic; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Warfarin | 1998 |
1 trial(s) available for azathioprine and omeprazole
| Article | Year |
|---|---|
Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agents.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Anti-Ulcer Agents; Antilymphocyte Serum; Azathioprine; Cimetidine; Cyclosporine; Drug Combinations; Famotidine; Female; Heart Transplantation; Humans; Intestinal Absorption; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Pirenzepine; Prednisone; Rats; Rats, Inbred BN | 1994 |
12 other study(ies) available for azathioprine and omeprazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Osteoporosis with underlying connective tissue disease: an unusual case.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Accidental Falls; Adult; Anti-Ulcer Agents; Antibodies, Antinuclear; Autoimmune Diseases; Azathioprine; Calcium; Connective Tissue Diseases; Fractures, Bone; Gastritis; Hernia, Hiatal; Humans; Hypogonadism; Immunosuppressive Agents; Klinefelter Syndrome; Lansoprazole; Lupus Erythematosus, Discoid; Male; Muscle Weakness; Omeprazole; Osteoporosis; Pain; Photosensitivity Disorders; Prednisolone; Testosterone | 2002 |
[Chronic upper abdominal pain without improvement after using proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Azathioprine; Duodenal Ulcer; Eosinophilia; Female; Gastritis; Gastroenteritis; Gastroscopy; Glucocorticoids; Humans; Immunosuppressive Agents; Lansoprazole; Middle Aged; Omeprazole; Prednisone; Proton Pump Inhibitors; Stomach Ulcer; Treatment Failure | 2004 |
Crohn's disease with isolated esophagus and gastric involvement.
Topics: Adult; Anti-Ulcer Agents; Azathioprine; Biopsy; Crohn Disease; Endoscopy, Gastrointestinal; Esophageal Diseases; Esophagus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Omeprazole; Stomach Ulcer; Ulcer | 2004 |
Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient.
Topics: Area Under Curve; Azathioprine; Clarithromycin; Drug Administration Schedule; Drug Interactions; Duodenitis; Half-Life; Heart Transplantation; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Tacrolimus | 2005 |
Increased liver enzyme levels during azathioprine treatment: beware of concomitant use of proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alanine Transaminase; Azathioprine; Dermatitis, Atopic; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Foot Dermatoses; gamma-Glutamyltransferase; Hand Dermatoses; Humans; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors | 2015 |
Pyloric stenosis as a manifestation of isolated gastric Crohn's disease responding to intralesional steroid injection and balloon dilation: a case report.
Topics: Abdominal Pain; Adult; Azathioprine; Crohn Disease; Dilatation; Endoscopy, Digestive System; Female; Humans; Immunosuppressive Agents; Omeprazole; Postprandial Period; Pyloric Stenosis; Treatment Outcome; Vomiting; Weight Loss | 2019 |